The Amgen Scholars Program provides hundreds of young scientists across the globe with access to cutting-edge scientific research experiences at leading educational institutions through a 12-year, $50-million commitment from the Amgen Foundation. Since 2006, the Amgen Scholars Program has provided those engaging, hands-on opportunities for more than 2,500 undergraduates from across the United States and Europe. The experience has been deeply transformative for many Scholars, as is evident by their stories and their trajectories on to scientific degree programs and careers.
Amgen Foundation has been, and continues to be, deeply committed to investing in STEM (science, technology, engineering, math) education and promoting science literacy. To ignite a passion for science in students, it is crucial that they have access to hands-on experiences in the classroom. Likewise, it is essential that teachers are equipped with the knowledge, resources and professional development opportunities needed to inspire their students.
Amgen Biotech Experience Expected to Reach 7,000 Rhode Island Students Over Next Two Years
The Amgen Foundation will invest more than $4 million to strengthen the Amgen Biotech Experience (ABE) program across the United States, Puerto Rico, United Kingdom and Ireland over the next two years. This includes awarding $100,000 to the University of Rhode Island (URI) to continue empowering Rhode Island teachers to inspire the next generations of scientists by giving their high school students access to the same lab equipment used by research scientists in the field today.
Amgen Biotech Experience Expected to Reach More Than 150,000 Students Over Next Two Years
Thousand Oaks, Calif., Oct. 21, 2015 /3BL Media/ – The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms.
“The two opportunities I have found most incredible have been meeting other budding scientists, both here at the NIH and from other Amgen sites while at the symposium in California, and absorbing as much as I possibly can from some of the nation's foremost scientists and career advisors.”